NEW YORK (Reuters) - Pfizer Inc, the largest U.S. drugmaker, expects no shortage of suitors for its consumer health business and said it would decide whether to sell, spin off or retain the unit next year.

Pfizer expects broad interest for consumer health business
Read More
Bagikan Berita Ini
0 Response to "Pfizer expects broad interest for consumer health business"
Posting Komentar